Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis
Methotrexate (MTX) is used as an anchor drug in the treatment of rheumatoid arthritis (RA), although more than a half of the patients with RA require additional treatments. We designed a prospective study involving two medical centers in Japan to examine the association between the expression of MTX...
Saved in:
Published in | Modern rheumatology Vol. 31; no. 6; pp. 1079 - 1086 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
02.11.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!